Nektar Therapeutics (NKTR) Construction in Progress (2010 - 2024)
Nektar Therapeutics' (NKTR) quarterly Construction in Progress came in at $245000.0 in Q4 2024, down 66.85% year-on-year from $739000.0 in Q1 2024, and up 77.54% quarter-over-quarter from $138000.0 in Q3 2024.
Nektar Therapeutics (NKTR) Construction in Progress (2010 - 2024) Analysis & Trends
Nektar Therapeutics' Construction in Progress history runs 15 years deep, the most recent figure standing at $245000.0 for Q4 2024.
- On a quarterly basis, Construction in Progress fell 66.85% year-over-year to $245000.0 in Q4 2024; TTM through Dec 2024 was $245000.0, a 66.85% decrease from a year earlier, with the FY2024 full-year figure at $245000.0, down 66.85% from the prior year.
- Construction in Progress improved to $245000.0 in Q4 2024 per NKTR's latest filing, from $138000.0 in the prior quarter.
- Across five years, Construction in Progress topped out at $7.2 million in Q4 2021 and bottomed at $138000.0 in Q3 2024.
- The 5-year median for Construction in Progress is $731500.0 (2023), against an average of $1.8 million.
- Biggest YoY gain for Construction in Progress was 57.05% in 2024; the steepest drop was 71.72% in 2024.
- Year by year, Construction in Progress stood at $4.7 million in 2020, then soared by 52.4% to $7.2 million in 2021, then slumped by 64.68% to $2.5 million in 2022, then plunged by 70.79% to $739000.0 in 2023, then plunged by 66.85% to $245000.0 in 2024.
- Per Business Quant, the three latest NKTR Construction in Progress figures stand at $245000.0 (Q4 2024), $138000.0 (Q3 2024), and $724000.0 (Q2 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 137.45 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Nektar Therapeutics | 2.04 Bn | 1.48 Bn | 3.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 245,000.00 |
| Sep 30, 2024 | 138,000.00 |
| Jun 30, 2024 | 724,000.00 |
| Dec 31, 2023 | 739,000.00 |
| Sep 30, 2023 | 488,000.00 |
| Jun 30, 2023 | 461,000.00 |
| Mar 31, 2023 | 811,000.00 |
| Dec 31, 2022 | 2.53 Mn |
| Dec 31, 2021 | 7.16 Mn |
| Dec 31, 2020 | 4.70 Mn |
| Dec 31, 2019 | 5.22 Mn |
| Dec 31, 2018 | 5.09 Mn |
| Dec 31, 2017 | 1.40 Mn |
| Dec 31, 2016 | 3.46 Mn |
| Dec 31, 2015 | 8.46 Mn |
| Dec 31, 2014 | 16.31 Mn |
| Dec 31, 2013 | 6.26 Mn |
| Dec 31, 2012 | 2.77 Mn |
| Dec 31, 2011 | 1.75 Mn |
| Dec 31, 2010 | 2.56 Mn |